Embecta (EMBC) Return on Capital Employed (2021 - 2026)
Embecta (EMBC) posted Return on Capital Employed of 33.63% for Q1 2026, down 4.48% sequentially from 35.21% in Q4 2025, and up 1379.0% YoY from 2.27% in Q1 2025.
Embecta (EMBC) Return on Capital Employed (2021 - 2026) Analysis & Trends
Embecta has reported Return on Capital Employed for 6 years, with the latest figure at 33.63% in Q1 2026.
- Quarterly Return on Capital Employed rose 1379.0% year-over-year to 33.63% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 33.63% (up 1379.0% YoY) and the FY2025 annual result came in at 26.13%, up 708.0% from the prior year.
- Return on Capital Employed declined to 33.63% in Q1 2026 per EMBC's latest filing, from 35.21% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 73.97% in Q1 2022 and troughed at 16.32% in Q4 2024.
- A 5-year average of 30.63% and a median of 25.18% in 2023 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2023 and 2025: Return on Capital Employed slumped 4577 bps in 2023, then jumped 1889 bps in 2025.
- Over 5 years, Return on Capital Employed stood at 36.53% in 2022, then tumbled by 45 bps to 20.03% in 2023, then dropped by 19 bps to 16.32% in 2024, then soared by 116 bps to 35.21% in 2025, then declined by 4 bps to 33.63% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 33.63%, 35.21%, and 28.07% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.86 Bn | 129.64 Bn | 1.96 Bn | 18.58% |
| 2 | Becton Dickinson | 52.40 Bn | 51.53 Bn | 2.32 Bn | 6.00% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 28.11% |
| 4 | Resmed | 33.87 Bn | 32.40 Bn | 861.22 Mn | 25.22% |
| 5 | Medline | 28.85 Bn | 26.17 Bn | 2.22 Bn | 5.57% |
| 6 | West Pharmaceutical Services | 25.04 Bn | 24.60 Bn | 329.20 Mn | 19.71% |
| 7 | Solventum | 15.35 Bn | 14.94 Bn | 1.29 Bn | 19.76% |
| 8 | Cooper Companies | 14.87 Bn | 14.73 Bn | 735.40 Mn | 4.68% |
| 9 | Baxter International | 13.61 Bn | 11.46 Bn | 1.03 Bn | 3.28% |
| 10 | Embecta | 312.57 Mn | 94.37 Mn | 153.30 Mn | 30.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.72% |
| Mar 31, 2026 | 33.63% |
| Dec 31, 2025 | 35.21% |
| Sep 30, 2025 | 28.07% |
| Jun 30, 2025 | 24.54% |
| Mar 31, 2025 | 19.84% |
| Dec 31, 2024 | 16.32% |
| Sep 30, 2024 | 18.48% |
| Jun 30, 2024 | 19.28% |
| Mar 31, 2024 | 18.01% |
| Dec 31, 2023 | 20.03% |
| Sep 30, 2023 | 25.18% |
| Jun 30, 2023 | 22.80% |
| Mar 31, 2023 | 28.20% |
| Dec 31, 2022 | 36.53% |
| Sep 30, 2022 | 40.36% |
| Jun 30, 2022 | 60.27% |
| Mar 31, 2022 | 73.97% |
| Dec 31, 2021 | 80.10% |